Empire Metals continues to up the scale of the Pitfield project - ICYMI
Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) this week outlined further progress at its Pitfield titaniu…
proactiveinvestors.co.uk
TAK(TAK)
TAK
Next earnings: Jul 30, 2026 · Before open
Signal
Leaning Bearish1↓
PRICE
Prev Close
16.63
Open
16.69
Day Range16.59 – 16.73
16.59
16.73
52W Range12.99 – 18.90
12.99
18.90
61% of range
VOLUME & SIZE
Avg Volume
2.9M
FUNDAMENTALS
P/E Ratio
43.7x
Premium valuation
EPS (TTM)
—
Div Yield
0.02%
Beta
0.39
Low vol
Performance
1D
-0.06%5D
-0.18%1M
-6.83%3M↓
-9.91%6M
+16.38%YTD
+6.67%1Y↑
+21.30%Best: 1Y (+21.30%)Worst: 3M (-9.91%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
59% gross marginValuation
EXPENSIVE
P/E 44x vs ~20x sectorHealth
MODERATE
CR 1.3 · FCF $500.69/shLean Bullish
Key MetricsTTM
Market Cap$8.34T
Revenue TTM$4.55T
Net Income TTM$193.19B
Free Cash Flow$757.21B
Gross Margin58.8%
Net Margin4.3%
Operating Margin10.5%
Return on Equity2.6%
Return on Assets1.2%
Debt / Equity0.63
Current Ratio1.27
EPS TTM$122.72
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
1 strong1 watch4 concern
28/100Liquidity
1.27Watch
Leverage
0.63Strong
Coverage
1.3xConcern
ROE
2.6%Concern
ROIC
2.6%Concern
Cash
$597.6BConcern
ANALYST COVERAGE6 analysts
BUY
Stock Health
Composite Score
2 of 5 signals bullish
4/10
Technicals
●
✗RSI RangeRSI 42 — Bearish momentum
Volume
●
✗Volume FlowDistribution — institutional selling
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
~LiquidityCurrent Ratio 1.27
Upcoming Events
EEarnings Report · Before OpenMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentSep 18, 2026
In 125 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
→ PullbackGolden Cross · 50D leads 200D by 10.4%
-5.2% vs SMA 50 · +4.6% vs SMA 200
Momentum
RSI42.3Momentum fading
MACD-0.27Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$18.90+13.8%
EMA 50
$17.13+3.2%
Current
$16.61
EMA 200
$16.08-3.2%
52W Low
$12.99-21.8%
52-Week RangeMid-range
$12.9961th %ile$18.90
Squeeze SetupVolume-based
Distribution PressureHeavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.
20-Day Money Flow
Acc days:3
Dist days:7
Edge:+4 dist
Volume Context
Avg Vol (50D)3.0M
Recent Vol (5D)
4.0M+34%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 8 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2026(current) | $4.6T $4.4T–$4.8T | — | $71.80 | — | ±2% | High8 |
FY2027 | $4.7T $4.7T–$4.7T | ▲ +1.5% | $75.79 | ▲ +5.6% | ±39% | Moderate4 |
FY2028 | $4.7T $4.6T–$4.9T | ▲ +1.1% | $102.36 | ▲ +35.1% | ±5% | High8 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryTAK
Last 8Q
-33.4%avg beat
Beat 4 of 8 quartersMissed 3-331%
Q2'24
+51%
Q3'24
+13%
Q4'24
-33%
Q1'25
+11%
Q3'25
—
Q4'25
-13%
Q1'26
+35%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →Neutral — mixed activity
90d▲ 1▼ 0
CitigroupOutperform
Apr 8
UPGRADE
Morgan StanleyOverweight
Apr 2
UPGRADE
Bank of America Sec…Buy
Mar 16
UPGRADE
Cowen & Co.Outperform
Jul 19
UPGRADE
Financials
Dividends3.79% yield
5 yrs of paymentsAnnual Yield3.79%
Semi-Annual Div.$0.2984
Est. Annual / Share$0.60
FrequencySemi-Annual
Q3'22
Q1'23
Q3'23
Q1'24
Q3'24
Q1'25
Q3'25
Q1'26
Dividend per payment — last 8 periods
INSTITUTIONAL OWNERSHIP
1
Capital Research Global Investors
19.1M▲2
FMR LLC
7.1M▲3
MORGAN STANLEY
6.5M▲4
ADAGE CAPITAL PARTNERS GP, L.L.C.
6.4M▲5
GOLDMAN SACHS GROUP INC
5.6M▲6
BRANDES INVESTMENT PARTNERS, LP
4.4M▲7
BlackRock, Inc.
3.2M▲8
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
3.1M▼News & Activity
TAK News
20 articles · 4h ago
Why 90% of Professional Fund Managers Lose to the S&P 500. Here's the One Strategy That Works
247wallst.com
Nvidia just updated its stock portfolio
finbold.com
Global X Emerging Markets Bond ETF Q1 2026 Commentary
seekingalpha.com
The Charles Schwab Corporation (SCHW) Analyst/Investor Day Transcript
seekingalpha.com
nVent Announces Share Repurchase Authorization
globenewswire.com
nVent Announces Quarterly Cash Dividend
globenewswire.com
Trump Loaded Up On Palantir Shares Months Before Publicly Praising Defense AI Giant On Truth Social, Records Reveal
benzinga.com
Calian Group Q2 Earnings Call Highlights
marketbeat.com
Constellation Software Q1 Earnings Call Highlights
marketbeat.com
DraftKings Eyes Prediction Markets as ‘Next Evolution' as Sportsbook Growth Holds Strong
marketbeat.com
Iraq exported 10 million barrels of oil through Strait of Hormuz in April
reuters.com
SHYG: The Truth Behind The Numbers
seekingalpha.com
Bill Ackman says Alphabet stake sale not a bet against the company
reuters.com
UK to set out looser bank ring-fencing rules next week, Sky News says
reuters.com
Vir Biotechnology: Trading Near Cash Value With A Huge Revenue Opportunity
seekingalpha.com
HCI Group: Synchrony In Fundamentals And Valuation Ensures Security
seekingalpha.com
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
businesswire.com
BTB Real Estate Investment Trust Q1 Earnings Call Highlights
marketbeat.com
Boyd Group Services Q1 Earnings Call Highlights
marketbeat.com
About
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Christophe Weber
Country
Japan
Website
Christophe WeberPresident, Chief Executive Officer & Representative Director
Andrew S. PlumpPresident of Research & Development and Representative Director
Iwaaki TaniguchiSenior Vice President of Corporate Finance & Controlling Department
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
TAK◀ | $16.61 | -0.06% | $52.5B | 43.0 | +745.3% | 235.6% | 1500 |
| $404.35 | -3.20% | $2.1T | 30.5 | +3296.8% | 4510.0% | 1500 | |
| $132.58 | -6.05% | $307.9B | 20.7 | -44.8% | 1012.0% | 1500 | |
| $88.38 | -2.58% | $303.7B | 13.6 | +318.8% | 1510.7% | 1500 | |
| $148.08 | -1.13% | $282.6B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $181.58 | -1.83% | $281.6B | 26.9 | +862.9% | 1745.9% | 1500 | |
| $183.40 | -0.23% | $256.1B | 16.8 | +213.3% | 1482.4% | 1500 | |
| Sector avg | — | -2.15% | — | 24.6 | +855.7% | 1865.8% | 1500 |